Re: "combined postmenopausal hormone therapy and cardiovascular disease: toward resolving the discrepancy between observational studies and the women's health initiative clinical trial"

Am J Epidemiol. 2006 Jun 1;163(11):1067-8; author reply 1068-9. doi: 10.1093/aje/kwj156. Epub 2006 Apr 26.
No abstract available

Publication types

  • Comment

MeSH terms

  • Aged
  • Bias
  • Cardiovascular Diseases / epidemiology*
  • Cardiovascular Diseases / prevention & control
  • Confounding Factors, Epidemiologic
  • Estrogen Replacement Therapy*
  • Estrogens, Conjugated (USP) / administration & dosage
  • Female
  • Humans
  • Incidence
  • Medroxyprogesterone Acetate / administration & dosage
  • Middle Aged
  • Observation
  • Postmenopause*
  • Randomized Controlled Trials as Topic
  • Research Design
  • Socioeconomic Factors
  • Time Factors
  • United States / epidemiology

Substances

  • Estrogens, Conjugated (USP)
  • Medroxyprogesterone Acetate